PubMed:12938574 / 221-377 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":156},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"No adverse event such as bleeding or thrombotic event had occurred, although clopidogrel has been discontinued two weeks after the coronary artery stenting."}

{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":131,"end":146},"obj":"http://purl.obolibrary.org/obo/UBERON_0001621"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":140,"end":146},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"}],"text":"No adverse event such as bleeding or thrombotic event had occurred, although clopidogrel has been discontinued two weeks after the coronary artery stenting."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":140,"end":146},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":131,"end":146},"obj":"http://purl.obolibrary.org/obo/UBERON_0001621"}],"text":"No adverse event such as bleeding or thrombotic event had occurred, although clopidogrel has been discontinued two weeks after the coronary artery stenting."}